These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9248766)

  • 1. Single-dose pharmacokinetics of paracetamol and its conjugates in Chinese non-insulin-dependent diabetic patients with renal impairment.
    Chan MT; Anderson PJ; Chan JC; Lau GS; Critchley JA
    Eur J Clin Pharmacol; 1997; 52(4):285-8. PubMed ID: 9248766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects.
    Critchley JA; Critchley LA; Anderson PJ; Tomlinson B
    J Clin Pharm Ther; 2005 Apr; 30(2):179-84. PubMed ID: 15811172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.
    Prescott LF; Speirs GC; Critchley JA; Temple RM; Winney RJ
    Eur J Clin Pharmacol; 1989; 36(3):291-7. PubMed ID: 2744070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol elimination in patients with non-insulin dependent diabetes mellitus.
    Kamali F; Thomas SH; Ferner RE
    Br J Clin Pharmacol; 1993 Jan; 35(1):58-61. PubMed ID: 8448070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracetamol disposition in renal allograft recipients.
    Martin U; Temple RM; Venkat-Raman G; Prescott LF
    Eur J Clin Pharmacol; 2002 Feb; 57(12):853-6. PubMed ID: 11936703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenous paracetamol in elderly patients.
    Liukas A; Kuusniemi K; Aantaa R; Virolainen P; Niemi M; Neuvonen PJ; Olkkola KT
    Clin Pharmacokinet; 2011 Feb; 50(2):121-9. PubMed ID: 21241071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracetamol test: modification by renal function, urine flow and pH.
    Kietzmann D; Bock KW; Krähmer B; Kettler D; Bircher J
    Eur J Clin Pharmacol; 1990; 39(3):245-51. PubMed ID: 2257860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects.
    Yin OQ; Tomlinson B; Chow AH; Chow MS
    Int J Pharm; 2001 Jul; 222(2):305-8. PubMed ID: 11427360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*).
    Graefe-Mody U; Friedrich C; Port A; Ring A; Retlich S; Heise T; Halabi A; Woerle HJ
    Diabetes Obes Metab; 2011 Oct; 13(10):939-46. PubMed ID: 21672124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE EFFECT OF TOTAL AND PARTIAL NEPHRECTOMY ON THE PHARMACOKINETICS OF INTRAVENOUS PARACETAMOL IN HUMANS.
    Karbownik A; Polom W; Porazka J; Szalek E; Grabowski T; Wolc A; Matuszewski Marcin ; Grzesowiak E
    Acta Pol Pharm; 2017 May; 74(3):929-935. PubMed ID: 29513963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired absorption of paracetamol in vegetarians.
    Prescott LF; Yoovathaworn K; Makarananda K; Saivises R; Sriwatanakul K
    Br J Clin Pharmacol; 1993 Sep; 36(3):237-40. PubMed ID: 9114910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan.
    Bienert A; Kamińska A; Olszewski J; Gracz J; Grabowski T; Wolc A; Grześkowiak E
    Pharmacol Rep; 2012; 64(2):421-7. PubMed ID: 22661194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.
    Martin U; Temple RM; Winney RJ; Prescott LF
    Eur J Clin Pharmacol; 1993; 45(2):141-5. PubMed ID: 8223835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracetamol disposition in Thai patients during and after treatment of falciparum malaria.
    Ismail S; Na Bangchang K; Karbwang J; Back DJ; Edwards G
    Eur J Clin Pharmacol; 1995; 48(1):65-9. PubMed ID: 7621851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracetamol metabolism in chronic liver disease.
    Forrest JA; Adriaenssens P; Finlayson ND; Prescott LF
    Eur J Clin Pharmacol; 1979 Jul; 15(6):427-31. PubMed ID: 499292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nizatidine on paracetamol and its metabolites in human plasma.
    Itoh H; Nagano T; Takeyama M
    J Pharm Pharmacol; 2002 Jun; 54(6):869-73. PubMed ID: 12079004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.
    Martin U; Temple RM; Winney RJ; Prescott LF
    Eur J Clin Pharmacol; 1991; 41(1):43-6. PubMed ID: 1782975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of metformin.
    Scheen AJ
    Clin Pharmacokinet; 1996 May; 30(5):359-71. PubMed ID: 8743335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracetamol and metabolite pharmacokinetics in infants.
    van der Marel CD; Anderson BJ; van Lingen RA; Holford NH; Pluim MA; Jansman FG; van den Anker JN; Tibboel D
    Eur J Clin Pharmacol; 2003 Jul; 59(3):243-51. PubMed ID: 12761605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.